Press Releases
Update on Neptune Technologies Notes
Thursday, November 27 2008
Neptune Technologies & Bioressources Inc. and Acasti Pharma Inc. announce that Neptune has assigned to Acasti Pharma all its obligations relating to the notes held by holders who have not accepted the Exchange into Acasti Pharma units...
 
Human clinical study demonstrates superior Neptune Krill Oil NKO® pharmacokinetic profile
Wednesday, November 19 2008
Neptune Technologies & Bioressources Inc. is pleased to announce positive results from a human clinical trial conducted in Germany in order to study the pharmacokinetic profile of Neptune Krill Oil...
 
Acasti Pharma completes offer to exchange outstanding Neptune Technologies dividend notes
Tuesday, October 21 2008
Acasti Pharma Inc. announced that it has acquired a majority of the 9,380,355 non-convertible notes issued by Neptune on August 11, 2008 in payment of the dividend declared July 17, 2008...
 
Neptune Technologies & Bioressources Inc. reports first quarter results
Friday, October 10 2008
Neptune Technologies & Bioressources Inc. today announced financial results for the fiscal 2009 first quarter ended August 31, 2008...
 
Neptune Technologies successfully completes $2.75 million private placement with 10% management participation
Thursday, October 09 2008
Proceeds to be used to support the achievement of several value-creating developments and commercial milestones of Acasti Pharma...
 
Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition
Thursday, September 25 2008
Neptune Technologies & Bioressources Inc. reported today that it entered a worldwide alliance with Marine Life Sciences who has entered into an agreement with Weider Global Nutrition for the distribution of dietary supplements...
 
Neptune Krill Oil, NKO®, enters WALGREENS, the largest U.S. retail pharmacy chain, under the brand name Schiff® MegaRed™
Monday, September 15 2008
Neptune Technologies & Bioressources Inc. reported today that its distributor Schiff Nutrition International Inc. has launched Schiff® MegaRed™ containing Neptune Krill Oil in Walgreens...
 
Neptune Technologies decided not to re-price options
Friday, September 12 2008
The Board of Directors of Neptune Technologies & Bioressources Inc. decided not to re-price any options including the previously announced 850,000 options owned by officers and directors...
 
Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
Monday, September 08 2008
Neptune Technologies & Bioressources Inc. announced today that it has entered into a new financing arrangement with Desjardins Group, which will provide the Company with up to $8.5 million in financing...
 
Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter
Thursday, August 28 2008
Neptune Technologies & Bioressources Inc. achieved record revenues for the fourth quarter of fiscal year 2008 and has achieved its sixth consecutive year of record revenues...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

We communicate

NTB (TSX) CAN$ 1.25 +0.02
NEPT (NASDAQ) US$ 1.17 -0.01
 

press releases

Investor Relations Contact NEPTUNE TECHNOLOGIES & BIORESSOURCES